Literature DB >> 21062189

Autoimmune dysfunction and subsequent renal insufficiency in a collegiate female athlete: a case report.

James E Leone1, Amie Kern, Joshua D Williamson, Robert M Colandreo.   

Abstract

OBJECTIVE: To present the case of a female collegiate basketball player who was diagnosed with Wegener granulomatosis of the eyes and immunoglobulin A (IgA) nephropathy.
BACKGROUND: A 19-year-old female collegiate basketball player presented to a rheumatologist, urologist, and nephrologist with severe eye pain and was diagnosed with Wegener granulomatosis and IgA nephropathy. At age 20, during routine follow-up testing, urine protein levels were found to be 3 times normal values (0-8 mg/dL), prompting the need for a kidney biopsy, which showed IgA nephropathy, another autoimmune disorder. DIFFERENTIAL DIAGNOSIS: Sinus infection, scleritis, lymphomatoid granulomatosis, Churg-Strauss syndrome, lupus erythematosus, general granulomatosis. TREATMENT: Initial assessment revealed signs and symptoms, particularly in the patient's eyes, consistent with a sinus infection and scleritis. Her corneas were examined by a specialist, who prescribed various medications, including prednisone, for the relief of symptoms. When the dosage of prednisone was reduced, symptoms returned. Further tests revealed the presence of anti-neutrophil cytoplasmic antibody, a protein associated with Wegener granulomatosis, which helped confirm the diagnosis. The following year, a routine urinalysis showed abnormal levels of protein in her urine. A kidney biopsy revealed that IgA nephropathy also was present. At the time of this case report, the athlete continues to be monitored by an ophthalmologist who specializes in Wegener granulomatosis, a rheumatologist, and a nephrologist. UNIQUENESS: This athlete presented with 2 rare autoimmune disorders at an early stage of life. The medications used to treat the disorders left the athlete fatigued on a daily basis. Additionally, she was placed on 3 immunosuppressant drugs, which increased her risk for further health complications, yet she was able to successfully compete in athletics at the collegiate level. No family history of renal disease or other autoimmune disorders was discovered, further adding to the complexity and uniqueness of this case.
CONCLUSIONS: Autoimmune disorders, such as Wegener granulomatosis, can present with a variety of common signs and symptoms. As athletic trainers, we encounter a host of unusual signs and symptoms; however, in cases such as this, further investigation into the cause of the chief complaints can go a long way toward restoring or managing an athlete's health. Excellent communication among the sports medicine team helped this athlete manage her potentially life-threatening condition while allowing her to remain active in her sport.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21062189      PMCID: PMC2978017          DOI: 10.4085/1062-6050-45.6.645

Source DB:  PubMed          Journal:  J Athl Train        ISSN: 1062-6050            Impact factor:   2.860


  10 in total

1.  Wegener granulomatosis.

Authors:  Nichole Graves
Journal:  Proc (Bayl Univ Med Cent)       Date:  2006-10

Review 2.  Wegener's granulomatosis: managing more than inflammation.

Authors:  Philip Seo
Journal:  Curr Opin Rheumatol       Date:  2008-01       Impact factor: 5.006

Review 3.  Wegener's granulomatosis: current trends in diagnosis and management.

Authors:  Vanessa R Erickson; Peter H Hwang
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2007-06       Impact factor: 2.064

Review 4.  The IgA nephropathy treatment dilemma.

Authors:  G B Appel; M Waldman
Journal:  Kidney Int       Date:  2006-06       Impact factor: 10.612

5.  The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener granulomatosis. A literature review and meta-analysis.

Authors:  J K Rao; M Weinberger; E Z Oddone; N B Allen; P Landsman; J R Feussner
Journal:  Ann Intern Med       Date:  1995-12-15       Impact factor: 25.391

6.  A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis.

Authors:  L Guillevin; J F Cordier; F Lhote; P Cohen; B Jarrousse; I Royer; P Lesavre; C Jacquot; P Bindi; P Bielefeld; J F Desson; F Détrée; A Dubois; E Hachulla; B Hoen; D Jacomy; C Seigneuric; D Lauque; M Stern; M Longy-Boursier
Journal:  Arthritis Rheum       Date:  1997-12

Review 7.  Modulating the progression in IgA nephropathy.

Authors:  James C M Chan; Howard Trachtman
Journal:  Nephron Clin Pract       Date:  2006-06-01

8.  Wegener's granulomatosis: Possible role of environmental agents in its pathogenesis.

Authors:  Daniel Albert; Cheryl Clarkin; Jodi Komoroski; Colleen M Brensinger; Jesse A Berlin
Journal:  Arthritis Rheum       Date:  2004-08-15

Review 9.  IgA nephropathy: an update.

Authors:  Bruce A Julian; Jan Novak
Journal:  Curr Opin Nephrol Hypertens       Date:  2004-03       Impact factor: 2.894

Review 10.  Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years.

Authors:  A S Fauci; B F Haynes; P Katz; S M Wolff
Journal:  Ann Intern Med       Date:  1983-01       Impact factor: 25.391

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.